Open menu
Paytm Money logo
Download App
UTI Mutual Fund

UTI Healthcare Fund Direct-Growth

NAV
returns change indicator
82.0275
as on 17 Jun 2019 09:05 PM
-0.8260(1.00%)
Last Change
Schemes Managed By
Investment Performance
would have given a returns of
110,871
star
121,647
star
89,875
star
92,531
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
7,469
Profit (absolute return)
7.47%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
8.71%
In the last 6 months
7.09%
In the last 1 year
7.60%
In the last 3 years
7.47%
In the last 5 years
28.24%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth
as of 17 Jun 2019 09:05 PM
402.00 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed less than 1 year
1.60%
Expense Ratio
Plan
Growth
2.03%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed less than 1 year
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 May 2019
Sort By
Healthcare
95.31%
383.14 Cr
Financial
2.62%
10.53 Cr
Cash Holding
2.03%
8.16 Cr
Sectors Holding in this Mutual Fund
as on 31 May 2019
Sort By
Healthcare
95.31%
383.14 Cr
Financial
2.62%
10.53 Cr
Cash Holding
2.03%
8.16 Cr
Companies Holding in this Mutual Fund
as on 31 May 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
10.43%
41.93 Cr
Lupin Ltd.
8.92%
35.86 Cr
Divi's Laboratories Ltd.
8.73%
35.09 Cr
Ipca Laboratories Ltd.
7.76%
31.20 Cr
Cipla Ltd.
7.65%
30.75 Cr
Cadila Healthcare Ltd.
6.29%
25.29 Cr
Sanofi India Ltd.
5.81%
23.36 Cr
Dr. Reddy's Laboratories Ltd.
5.67%
22.79 Cr
Pfizer Ltd.
4.49%
18.05 Cr
FDC Ltd.
4.22%
16.96 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 May 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
10.43%
41.93 Cr
Lupin Ltd.
8.92%
35.86 Cr
Divi's Laboratories Ltd.
8.73%
35.09 Cr
Ipca Laboratories Ltd.
7.76%
31.20 Cr
Cipla Ltd.
7.65%
30.75 Cr
Cadila Healthcare Ltd.
6.29%
25.29 Cr
Sanofi India Ltd.
5.81%
23.36 Cr
Dr. Reddy's Laboratories Ltd.
5.67%
22.79 Cr
Pfizer Ltd.
4.49%
18.05 Cr
FDC Ltd.
4.22%
16.96 Cr
View All
View All
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager V Srivatsa. It has an AUM of ₹402.00 Crores and the latest NAV decalared is ₹82.028 as on 17 Jun 2019 at 9:05 pm.
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is -7.59%, in last 3 years is -7.47% and 71.89% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
AMC Information
UTI Mutual Fund
UTI Mutual Fund
View AMC Details
163,825.23 Cr
AUM
200
Schemes
Address
Address
UTI Tower, 'GN' Block,Bandra-Kurla Complex,Bandra (East),400051
Phone Number
Phone Number
Phone : 022- 6678 6666, 66786354/ 1800 22 1230
Fax : (022) 26523031